VC Investment In Diagnostics And Eyes Delivering Strongest Returns

For the past five years, venture capital investments in eye companies and those producing new diagnostics have delivered the strongest returns for device investors, according to our survey of more than 70 venture-backed companies acquired over the past five years. ( See "Device VCs Find New Hope in Old Exit Path," IN VIVO, July 2010Also see "Device VCs Find New Hope in Old Exit Path" - In Vivo, 1 July, 2010..) However, cardiovascular and orthopedic companies, including those working in the spine, continue to be among the more prolific sources of exits.

To be included in the study the companies needed to fit two criteria. They had to be venture-backed, and the...